Cargando…
Peripheral administration of nanomicelle-encapsulated anti-Aβ oligomer fragment antibody reduces various toxic Aβ species in the brain
BACKGROUND: Although a large amount of evidence has revealed that amyloid β (Aβ), especially Aβ oligomers, protofibrils, and pyroglutamated Aβs, participate primarily in the pathophysiological processes of Alzheimer’s disease, most clinical trials of anti-Aβ antibody therapy have never acquired succ...
Autores principales: | Amano, Akiko, Sanjo, Nobuo, Araki, Wataru, Anraku, Yasutaka, Nakakido, Makoto, Matsubara, Etsuro, Tomiyama, Takami, Nagata, Tetsuya, Tsumoto, Kouhei, Kataoka, Kazunori, Yokota, Takanori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9888736/ https://www.ncbi.nlm.nih.gov/pubmed/36721182 http://dx.doi.org/10.1186/s12951-023-01772-y |
Ejemplares similares
-
Reversibility of Aβ oligomer neurotoxicity
por: Araki, Wataru
Publicado: (2017) -
Ligand Installation to Polymeric Micelles for Pediatric Brain Tumor Targeting
por: Watanabe, Takayoshi, et al.
Publicado: (2023) -
Conformational features and interaction mechanisms of V(H)H antibodies with β‐hairpin CDR3: A case of Nb8‐HigB2 interaction
por: Yamamoto, Koichi, et al.
Publicado: (2023) -
Mutations in the β-amyloid precursor protein in familial Alzheimer’s disease increase Aβ oligomer production in cellular models
por: Ohshima, Yoichi, et al.
Publicado: (2018) -
Disease Modifying Therapies for Alzheimer's Disease Targeting Aβ Oligomers: Implications for Therapeutic Mechanisms
por: Matsubara, Etsuro, et al.
Publicado: (2013)